On the public citation graph

SAR study on inhibitors of GIIA secreted phospholipase A2 using machine learning methods

https://doi.org/10.1111/cbdd.13470
0 signed · 91 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2013.282836openalex-snapshot
Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome
inferredcites →https://doi.org/10.1002/emmm.201000072openalex-snapshot
A novel anti‐inflammatory role for secretory phospholipase A2 in immune complex‐mediated arthritis
inferredcites →https://doi.org/10.1007/bf00994018openalex-snapshot
Support-Vector Networks
inferredcites →https://doi.org/10.1007/s00894-004-0186-9openalex-snapshot
Impact of descriptor vector scaling on the classification of drugs and nondrugs with artificial neural networks
inferredcites →https://doi.org/10.1007/s10557-008-6132-9openalex-snapshot
Phospholipase A2 Biochemistry
inferredcites →https://doi.org/10.1007/s10822-010-9319-7openalex-snapshot
Design of new secreted phospholipase A2 inhibitors based on docking calculations by modifying the pharmacophore segments of the FPL67047XX inhibitor
inferredcites →https://doi.org/10.1007/s11030-017-9743-xopenalex-snapshot
Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors
inferredcites →https://doi.org/10.1016/bs.ai.2016.05.001openalex-snapshot
The Roles of the Secreted Phospholipase A2 Gene Family in Immunology
inferredcites →https://doi.org/10.1016/j.bmc.2007.10.077openalex-snapshot
Design of new potent and selective secretory phospholipase A2 inhibitors. Part 5: Synthesis and biological activity of 1-alkyl-4-[4,5-dihydro-1,2,4-[4H]-oxadiazol-5-one-3-ylmethylbenz-4′-yl(oyl)] piperazines
inferredcites →https://doi.org/10.1016/j.bmc.2010.03.049openalex-snapshot
Design of new potent and selective secretory phospholipase A2 inhibitors. 6-Synthesis, structure–activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives
inferredcites →https://doi.org/10.1016/j.bmc.2010.12.030openalex-snapshot
Inhibition of secreted phospholipases A2 by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations
inferredcites →https://doi.org/10.1016/j.bmc.2011.04.039openalex-snapshot
Quinoline-4-methyl esters as human nonpancreatic secretory phospholipase A2 inhibitors
inferredcites →https://doi.org/10.1016/j.bmc.2016.02.040openalex-snapshot
Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations
inferredcites →https://doi.org/10.1016/j.bmcl.2006.01.117openalex-snapshot
Synthesis of phospholipase A2 inhibitory biflavonoids
inferredcites →https://doi.org/10.1016/j.bmcl.2008.09.041openalex-snapshot
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA
inferredcites →https://doi.org/10.1016/j.bmcl.2012.10.080openalex-snapshot
Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin αvβ3
inferredcites →https://doi.org/10.1016/j.ejmech.2012.10.057openalex-snapshot
Optimization of 5-hydroxytryptamines as dual function inhibitors targeting phospholipase A2 and leukotriene A4 hydrolase
inferredcites →https://doi.org/10.1016/j.ejmech.2016.02.025openalex-snapshot
Synthesis of new secretory phospholipase A2-inhibitory indole containing isoxazole derivatives as anti-inflammatory and anticancer agents
inferredcites →https://doi.org/10.1016/j.jtcvs.2012.08.003openalex-snapshot
Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo
inferredcites →https://doi.org/10.1016/j.phrs.2016.08.035openalex-snapshot
Celastrol modulates inflammation through inhibition of the catalytic activity of mediators of arachidonic acid pathway: Secretory phospholipase A 2 group IIA, 5-lipoxygenase and cyclooxygenase-2
inferredcites →https://doi.org/10.1016/s0002-9440(10)64886-9openalex-snapshot
Expression of Group IIA Secretory Phospholipase A2 Is Elevated in Prostatic Intraepithelial Neoplasia and Adenocarcinoma
inferredcites →https://doi.org/10.1016/s0021-9258(18)83549-9openalex-snapshot
Cloning and Recombinant Expression of Phospholipase A2 Present in Rheumatoid Arthritic Synovial Fluid
inferredcites →https://doi.org/10.1016/s0040-4039(00)81975-9openalex-snapshot
New empirical models of substituent polarisability and their application to stabilisation effects in positively charged species
inferredcites →https://doi.org/10.1016/s0040-4039(01)94977-9openalex-snapshot
A new model for calculating atomic charges in molecules
inferredcites →https://doi.org/10.1016/s0169-409x(96)00423-1openalex-snapshot
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
inferredcites →https://doi.org/10.1016/s0960-894x(00)80622-8openalex-snapshot
Vinylogous hydroxamic acids: 5-lipoxygenase inhibitors
inferredcites →https://doi.org/10.1016/s0960-894x(01)00472-3openalex-snapshot
Novel 3-dodecanoylindole-2-carboxylic acid inhibitors of cytosolic phospholipase A2
inferredcites →https://doi.org/10.1016/s0960-894x(96)00499-4openalex-snapshot
A simple synthesis of biaryl phospholipase A2 inhibitors: Probing hydrophobic effects
inferredcites →https://doi.org/10.1016/s0960-894x(98)00641-6openalex-snapshot
Design and synthesis of new secretory phospholipase A2 inhibitor of a phospholipid analog
inferredcites →https://doi.org/10.1016/s0960-894x(98)00721-5openalex-snapshot
Synthesis and PLA2-inhibitory properties of 2(R)-acetamido-alkylphosphomethanols with a variable aggregate anchor
inferredcites →https://doi.org/10.1016/s0960-894x(99)00680-0openalex-snapshot
Synthesis and enzyme inhibitory activities of a series of lipidic diamine and aminoalcohol derivatives on cytosolic and secretory phospholipases A2
inferredcites →https://doi.org/10.1021/acs.molpharmaceut.6b00471openalex-snapshot
ADMET Evaluation in Drug Discovery. 16. Predicting hERG Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches
inferredcites →https://doi.org/10.1021/acs.molpharmaceut.7b00317openalex-snapshot
ADMET Evaluation in Drug Discovery. Part 17: Development of Quantitative and Qualitative Prediction Models for Chemical-Induced Respiratory Toxicity
inferredcites →https://doi.org/10.1021/acs.molpharmaceut.7b00631openalex-snapshot
ADMET Evaluation in Drug Discovery. 18. Reliable Prediction of Chemical-Induced Urinary Tract Toxicity by Boosting Machine Learning Approaches
inferredcites →https://doi.org/10.1021/ci100050topenalex-snapshot
Extended-Connectivity Fingerprints
inferredcites →https://doi.org/10.1021/ci100217kopenalex-snapshot
Molecular Docking and 3D-QSAR CoMFA Studies on Indole Inhibitors of GIIA Secreted Phospholipase A2
inferredcites →https://doi.org/10.1021/ci9704423openalex-snapshot
Overcoming the Limitations of a Connection Table Description: A Universal Representation of Chemical Species
inferredcites →https://doi.org/10.1021/cr200085wopenalex-snapshot
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
inferredcites →https://doi.org/10.1021/ja00134a023openalex-snapshot
Autocorrelation of Molecular Surface Properties for Modeling Corticosteroid Binding Globulin and Cytosolic Ah Receptor Activity by Neural Networks
inferredcites →https://doi.org/10.1021/jm00031a001openalex-snapshot
Discovery of new non-phospholipid inhibitors of the secretory phospholipases A2
inferredcites →https://doi.org/10.1021/jm00072a025openalex-snapshot
N-(Carboxymethyl)-N-[3,5-bis(decyloxy)phenyl]glycine (Ro 23-9358): a potent inhibitor of secretory phospholipases A2 with antiinflammatory activity
inferredcites →https://doi.org/10.1021/jm0401309openalex-snapshot
Carbocyclic[g]indole Inhibitors of Human Nonpancreatic s-PLA2
inferredcites →https://doi.org/10.1021/jm060082nopenalex-snapshot
Inhibition of Secreted Phospholipase A2. 4-Glycerol Derivatives of 4,5-Dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with Broad Activities
inferredcites →https://doi.org/10.1021/jm060136topenalex-snapshot
The First Potent Inhibitor of Mammalian Group X Secreted Phospholipase A2: Elucidation of Sites for Enhanced Binding
inferredcites →https://doi.org/10.1021/jm0700823openalex-snapshot
Synthesis and Pharmacological Evaluation of a Selected Library of New Potential Anti-inflammatory Agents Bearing the γ-Hydroxybutenolide Scaffold: a New Class of Inhibitors of Prostanoid Production through the Selective Modulation of Microsomal Prostaglandin E Synthase-1 Expression
inferredcites →https://doi.org/10.1021/jm7010707openalex-snapshot
Chemically Induced Dimerization of Human Nonpancreatic Secretory Phospholipase A2 by Bis-indole Derivatives
inferredcites →https://doi.org/10.1021/jm800422vopenalex-snapshot
Highly Specific and Broadly Potent Inhibitors of Mammalian Secreted Phospholipases A2
inferredcites →https://doi.org/10.1021/jm8010096openalex-snapshot
Discovery of Multitarget Inhibitors by Combining Molecular Docking with Common Pharmacophore Matching
inferredcites →https://doi.org/10.1021/jm960395qopenalex-snapshot
Potent Inhibitors of Secretory Phospholipase A2: Synthesis and Inhibitory Activities of Indolizine and Indene Derivatives
inferredcites →https://doi.org/10.1021/jm960437aopenalex-snapshot
Synthesis and Phospholipase A2 Inhibitory Activity of Thielocin B3 Derivatives
inferredcites →https://doi.org/10.1021/jm960485vopenalex-snapshot
Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 1. Indole-3-acetamides
inferredcites →https://doi.org/10.1021/jm960486nopenalex-snapshot
Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 2. Indole-3-acetamides with Additional Functionality
inferredcites →https://doi.org/10.1021/jm960487fopenalex-snapshot
Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 3. Indole-3-glyoxamides
inferredcites →https://doi.org/10.1021/jm980027hopenalex-snapshot
Synthesis and Comparison of the Antiinflammatory Activity of Manoalide and Cacospongionolide B Analogues
inferredcites →https://doi.org/10.1021/np000637wopenalex-snapshot
New Sesquiterpene Derivatives from the Sponge Dysidea Species with a Selective Inhibitor Profile against Human Phospholipase A2 and Other Leukocyte Functions
inferredcites →https://doi.org/10.1021/np980122topenalex-snapshot
A New Cacospongionolide Inhibitor of Human Secretory Phospholipase A2 from the Tyrrhenian Sponge Fasciospongia cavernosa and Absolute Configuration of Cacospongionolides
inferredcites →https://doi.org/10.1023/a:1008763405023openalex-snapshot
Calculating partition coefficient by atom-additive method
inferredcites →https://doi.org/10.1023/a:1010933404324openalex-snapshot
Random Forests
inferredcites →https://doi.org/10.1023/a:1012487302797openalex-snapshot
Gene Selection for Cancer Classification using Support Vector Machines
inferredcites →https://doi.org/10.1038/bjc.1994.229openalex-snapshot
Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency
inferredcites →https://doi.org/10.1038/nsb0695-458openalex-snapshot
Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2
inferredcites →https://doi.org/10.1038/srep24817openalex-snapshot
Constructing and Validating High-Performance MIEC-SVM Models in Virtual Screening for Kinases: A Better Way for Actives Discovery
inferredcites →https://doi.org/10.1074/jbc.270.1.274openalex-snapshot
Mechanism of Inhibition of Human Nonpancreatic Secreted Phospholipase A2 by the Anti-inflammatory Agent BMS-181162*
inferredcites →https://doi.org/10.1080/03610927408827101openalex-snapshot
A dendrite method for cluster analysis
inferredcites →https://doi.org/10.1080/13543776.2017.1246540openalex-snapshot
Inhibitors of phospholipase A2and their therapeutic potential: an update on patents (2012-2016)
inferredcites →https://doi.org/10.1093/eurheartj/ehq374openalex-snapshot
Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease
inferredcites →https://doi.org/10.1109/tpami.2002.1017616openalex-snapshot
An efficient k-means clustering algorithm: analysis and implementation
inferredcites →https://doi.org/10.1111/cbdd.12307openalex-snapshot
Discovery of Novel Secretory Phospholipase A2Inhibitors Using Virtual Screen
inferredcites →https://doi.org/10.1136/gut.35.11.1593openalex-snapshot
Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
inferredcites →https://doi.org/10.1159/000468890openalex-snapshot
Development of a Radioimmunoassay for Human Group-II Phospholipase A2 and Demonstration of Postoperative Elevation
inferredcites →https://doi.org/10.1161/circulationaha.110.950733openalex-snapshot
The sPLA2Inhibition to Decrease Enzyme Release After Percutaneous Coronary Intervention (SPIDER-PCI) Trial
inferredcites →https://doi.org/10.1186/s13321-016-0117-7openalex-snapshot
ADMET evaluation in drug discovery: 15. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling
inferredcites →https://doi.org/10.1194/jlr.r058123openalex-snapshot
A new era of secreted phospholipase A2
inferredcites →https://doi.org/10.1194/jlr.r800033-jlr200openalex-snapshot
Phospholipase A2 structure/function, mechanism, and signaling
inferredcites →https://doi.org/10.1515/cclm.1987.25.8.505openalex-snapshot
Improved Method for the Determination of Phospholipase A2 Catalytic Activity Concentration in Human Serum and Ascites
inferredcites →https://doi.org/10.2174/092986705774462860openalex-snapshot
Inhibitors of Secretory Phospholipase A2 Group IIA
inferredcites →https://doi.org/10.4018/978-1-60566-766-9.ch015openalex-snapshot
Machine Learning Applications in Mega-Text Processing
inferredcites →https://doi.org/10.4172/1948-5956.1000357openalex-snapshot
Phospholipase A2: A Potential Therapeutic Target in Inflammation and Cancer (In silico, In vitro, In vivo and Clinical Approach)
inferredcites →https://doi.org/10.7164/antibiotics.45.1071openalex-snapshot
A novel type of phospholipase A2 inhibitor, thielocin A1.BETA., and mechanism of action.
inferredcites →https://doi.org/10.7164/antibiotics.45.50openalex-snapshot
Cinatrins, a novel family of phospholipase A2 inhibitors. II. Biological activities.
inferredcites →https://doi.org/10.7164/antibiotics.48.106openalex-snapshot
Isolation and Biological Activity of Thielocins: Novel Phospholipase A2 Inhibitors Produced by Thielavia terricola RF-143.

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1007/s11030-021-10343-yopenalex-snapshot
Analysis of the uncharted, druglike property space by self-organizing maps
inferred← citeshttps://doi.org/10.1007/s11030-022-10466-wopenalex-snapshot
Classification models and SAR analysis on HDAC1 inhibitors using machine learning methods
inferred← citeshttps://doi.org/10.1016/b978-0-443-15177-4.00010-8openalex-snapshot
Sensors and model-based approaches applied for phospholipase activity detection
inferred← citeshttps://doi.org/10.1016/b978-0-443-15177-4.00016-9openalex-snapshot
Systems biology approaches to unveiling the expression of phospholipases in various types of cancer—Transcriptomics and protein-protein interaction networks
inferred← citeshttps://doi.org/10.1016/b978-0-443-21800-2.00022-1openalex-snapshot
The importance of phospholipases A2 in Alzheimer's disease mechanisms, pathology, and potential therapies
inferred← citeshttps://doi.org/10.1021/acs.chemrestox.2c00330openalex-snapshot
Prediction and Structure–Activity Relationship Analysis on Ready Biodegradability of Chemical Using Machine Learning Method
inferred← citeshttps://doi.org/10.1021/acsomega.2c02983openalex-snapshot
Machine Learning Enabled Structure-Based Drug Repurposing Approach to Identify Potential CYP1B1 Inhibitors
inferred← citeshttps://doi.org/10.1080/1062936x.2022.2078880openalex-snapshot
Classification models and SAR analysis on thromboxane A2 synthase inhibitors by machine learning methods
inferred← citeshttps://doi.org/10.1080/13543776.2020.1798402openalex-snapshot
Inhibitory activities of indolizine derivatives: a patent review
inferred← citeshttps://doi.org/10.1080/13543784.2026.2727499openalex-snapshot
Varespladib for snakebite envenoming: insights from therapeutic development and clinical trials
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.